UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
(AMENDMENT NO. 2)
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Advanced Cell Technology, Inc.
---------------------
(Name of Issuer)
Common Stock, $.001 par value
--------------------------------------------------------------------------------
(Title of Class of Securities)
00088R105
--------------------------------------------------------------------------------
(CUSIP Number)
Alessandro Grande Brian M. Hand, Esq.
Sagio Investments SA Nordlicht & Hand
11 Cours De Rive 645 Fifth Avenue
1204 Geneva New York, NY 10022
Switzerland (212) 421-6500
(212) 265-5659
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
May 24, 2006
----------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of ss.ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the
following box [x].
----------------------------
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act.
CUSIP No. 00088R105
1 Name of Reporting Person.
Sagio Investments SA
I.R.S. Identification Nos. of Above Persons (entities only).
--------------------------------------------------------------------------------
2 Check the Appropriate Box if a Member of a Group (See Instructions)
(a).................................................................[ ]
(b).................................................................[ ]
--------------------------------------------------------------------------------
3 SEC Use Only
--------------------------------------------------------------------------------
4 Source of Funds (See Instructions) WC
--------------------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is Required Pursuant to Items
2(d) or 2(e) [ ]
--------------------------------------------------------------------------------
6 Citizenship or Place of Organization
Switzerland
--------------------------------------------------------------------------------
Number of
Shares 7 Sole Voting Power..........................941,000**
Beneficially
Owned by 8 Shared Voting Power........................0
Each
Reporting 9 Sole Dispositive Power.....................941,000**
Person
With 10 Shared Dispositive Power...................0
--------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Reporting Persons....941,000**
--------------------------------------------------------------------------------
12 Check if the Aggregate Amount in Row (11) Excludes Certain Shares
(See Instructions) [ ]
--------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
3.96%
--------------------------------------------------------------------------------
14 Type of Reporting Person (See Instructions) OO
--------------------------------------------------------------------------------
*Neither the filing of this Schedule 13D nor any of its contents shall be deemed
to constitute an admission by Sagio Investments SA that it is the beneficial
owner of any of the Common Stock of Advanced Cell Technology, Inc. referred to
herein for purposes of Section 13(d) of the Securities
Exchange Act of 1934, as amended, or for any other purpose, and such beneficial
ownership is expressly disclaimed.
Item 1. Security and Issuer.
This statement on Schedule 13D relates to the Common Stock, par value $.001
per share, of Advanced Cell Technology, Inc., (the "Issuer"). The principal
executive offices of the Issuer is located at 381 Plantation Street, Worcester,
Massachusetts 01605.
Item 2. Identity and Background.
(a) The name of the person filing this statement is Sagio Investments
SA (the "Reporting Person").
(b) The Reporting Person's principal business office is located at 11
Cours De Rive, 1204 Geneva, Switzerland.
(c) The Reporting Person manages the Longview Fund for and on behalf of
clients and investors located outside the United States who have the right to
receive or the power to direct the receipt of dividends from, or the proceeds
from the sale of, the securities referenced herein.
(d) During the past five years, the Reporting Person has not been
convicted in a criminal proceeding.
(e) During the past five years, the Reporting Person has not been a party
to a civil proceeding of a judicial or administrative body of competent
jurisdiction and as a result of which Reporting Person was or is subject to a
judgment, decree or final order enjoining future violations of or prohibiting or
mandating activities subject to Federal or State securities laws or finding any
violation with respect to such laws.
(f) Switzerland.
Item 3. Source and Amount of Funds or Other Consideration.
The Reporting Person previously filed a Schedule 13G with the Commission
pursuant to ss.240.13d-1(c) on January 9, 2006, as amended on February 23, 2006,
which details the Reporting Person's acquisition of the Issuer's securities.
Item 4. Purpose of Transaction.
(a-j) Not applicable.
Item 5. Interest in Securities of the Issuer.
(a) The Reporting Person owns 941,000 shares of Common Stock, par value
$.001 per share, of the Issuer equivalent to approximately 3.96% of the Common
Stock of such class.*
(b) The Reporting Person has the sole power to direct the vote of all such
shares.
(c) The transactions in the Issuer Common Stock that were effected by the
Reporting Person, in the open market by individual purchases, during the past 60
days were the following:
(1) Sale of 25,000 shares at $1.16 per share on May 1, 2006
(2) Sale of 110,000 shares at $1.17 per share on May 2, 2006
(3) Sale of 100,000 shares at $1.16 per share on May 3, 2006
(4) Sale of 125,000 shares at $1.18 per share on May 4, 2006
(5) Sale of 60,000 shares at $1.19 per share on May 5, 2006
(6) Sale of 210,000 shares at $1.21 per share on May 8, 2006
(7) Sale of 50,000 shares at $1.22 per share on May 9, 2006
(8) Sale of 120,000 shares at $1.26 per share on May 10, 2006
(9) Sale of 150,000 shares at $1.32 per share on May 11, 2006
(10) Sale of 85,000 shares at $1.40 per share on May 12, 2006
(11) Sale of 50,000 shares at $1.39 per share on May 15, 2006
(12) Sale of 60,000 shares at $1.43 per share on May 16, 2006
(13) Sale of 45,000 shares at $1.39 per share on May 17, 2006
(14) Sale of 20,000 shares at $1.36 per share on May 18, 2006
(15) Sale of 35,000 shares at $1.30 per share on May 19, 2006
(16) Sale of 50,000 shares at $1.32 per share on May 22, 2006
(17) Sale of 50,000 shares at $1.27 per share on May 23, 2006
(18) Sale of 30,000 shares at $1.24 per share on May 24, 2006
Item 6. Contracts, Arrangements, Understandings or Relationships with Respect
to securities of the Issuer.
None.
Item 7. Materials to be Filed as Exhibits.
None.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
Date: May 26, 2006
----------------------------
SAGIO INVESTMENTS SA
By: /s/ Alessandro Grande
-----------------------------------------
Alessandro Grande
Administrateur and Investment Manager